Landscapes / Companies
Treeline Biosciences, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
4 in Phase 1
Drugs
4
in active trials
Trials
4 active
4 since 2021
Drugs4
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1 | 29 Aug 2030Phase 1 trial completes | |||
| Next date | 29 Aug 2030 · Phase 1 trial completes | ||||
| Also tested for | Small Cell Lung Cancer ( SCLC ), Neuroendocrine Cancer and 2 more | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2030Phase 1 trial completes | |||
| Next date | Sep 2030 · Phase 1 trial completes | ||||
| Also tested for | Lymphoma, Lymphoma, Non Hodgkin | ||||
| Open drug page | |||||
— |
Phase 1 | Sep 2030Phase 1 trial completes | |||
| Next date | Sep 2030 · Phase 1 trial completes | ||||
| Also tested for | Lymphoma, Lymphoma, Non Hodgkin | ||||
| Open drug page | |||||
— |
Phase 1 | 3 Dec 2031Phase 1 trial completes | |||
| Next date | 3 Dec 2031 · Phase 1 trial completes | ||||
| Also tested for | KRAS Mutant Solid Tumors | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021